Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAIV-T liquid formulation in healthy children
NCT00192374Phase 3Completed
- Sponsor
- MedImmune
- Start
- Feb 2002
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of live attenuated influenza vaccine in influenza (4 arms), sponsored by MedImmune. Primary endpoint: First episode of culture-confirmed influenza illness caused by community-acquired subtypes antigenically similar to those contained in the vaccine. Started Feb 2002; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00192374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00192374.